IndraLab

Statements

reach
"Thus, MYSM1 is a key inhibitor of innate immunity and autoimmunity and may represent a therapeutic agent in the treatment of infectious, inflammatory, and autoimmune diseases.Initial experiments evalu[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"
33086059
reach
"Thus, MYSM1 is a key suppressor of innate immunity and autoimmunity and represents a potential therapeutic agent for infectious, inflammatory, and autoimmune diseases."
33086059
reach
"Studies have found that MYSM1 was a key inhibitor of innate immunity and autoimmunity."
34670246
eidos
"MYSM1 Represses Innate Immunity and Autoimmunity through Suppressing the cGAS-STING Pathway ."
33086059
reach
"The level of IFN-β , IL-6, and Cxcl10 mRNAs ( Figure 2 G), the expression of IFN-β, IL-6, and TNF-α proteins ( Figure 2 H), and the phosphorylation of TBK1 and IRF3 proteins ( Figure 2 I) induced by H[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"
33086059